Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Shareholders' Equity

GlaxoSmithKline CR`s Shareholders' Equity reached 1,520 CZK mil in 2017. This is 0.266 % less than in the previous year.

$1.99

Buy Shareholders' Equity data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             169 198 167 207 183    
Bayer Czech Republic CZK mil ... ... ...                 460 289 286 243 246    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 1,363 1,369 1,340 1,301 1,338    
Merck Czech Republic CZK mil ... ...                   225 289 316 351 419    
Novartis Czech Republic CZK mil                       238 292 340 423 505    
Pfizer Czech Republic CZK mil ... ...                   1,034 1,043 1,562 1,696 1,180    
Roche Czech Republic CZK mil ... ... ...                 1,065 1,104 1,239 1,134 1,185   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               528 574 639 640 699    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 33.2 46.8 60.4 75.2    
Walmark CZK mil ... ... ...                 1,223 368 637 667 -85.0